Literature DB >> 10022258

Epidemiology of cancer: global patterns and trends.

D M Parkin1.   

Abstract

This paper presents recent estimates of the global cancer burden, in terms of the number of new cancer cases, and incidence rates, ignoring other measures such as mortality, prevalence and years of life lost. For four major cancers, information on temporal trends is reviewed, at least for those parts of the world where adequate data are available. Finally, there is a brief examination of the factors underlying the geographic patterns and trends, with an attempt at quantitation, and some forecasting of the likely evolution of the cancer burden at the global level.

Entities:  

Mesh:

Year:  1998        PMID: 10022258     DOI: 10.1016/s0378-4274(98)00311-7

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  19 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  The impact of capsaicin intake on risk of developing gastric cancers: a meta-analysis.

Authors:  Noel Pabalan; Hamdi Jarjanazi; Hilmi Ozcelik
Journal:  J Gastrointest Cancer       Date:  2014-09

3.  A multiple-center phase II study of weekly docetaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer.

Authors:  Jen-Shi Chen; Yen-Yang Chen; Jen-Sheng Huang; Kun-Yun Yeh; Ping-Tsung Chen; Wen-Chi Shen; Hung-Chih Hsu; Yung-Chung Lin; Hung-Ming Wang
Journal:  Gastric Cancer       Date:  2011-06-08       Impact factor: 7.370

4.  Expression of bile acid receptor TGR5 in gastric adenocarcinoma.

Authors:  Weibiao Cao; Wei Tian; Jie Hong; Dan Li; Rosemarie Tavares; Lelia Noble; Steven F Moss; Murray B Resnick
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-12-13       Impact factor: 4.052

5.  Down-regulation of claudin-3 is associated with proliferative potential in early gastric cancers.

Authors:  Takuya Okugawa; Tadayuki Oshima; Xin Chen; Kazutoshi Hori; Toshihiko Tomita; Hirokazu Fukui; Jiro Watari; Takayuki Matsumoto; Hiroto Miwa
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

6.  Determination of urinary 5-hydroxyindoleacetic acid as a metabolomics in gastric cancer.

Authors:  Maral Mokhtari; Amin Rezaei; Ali Ghasemi
Journal:  J Gastrointest Cancer       Date:  2015-06

7.  LINE-1 family member GCRG123 gene is up-regulated in human gastric signet-ring cell carcinoma.

Authors:  Gang-Shi Wang; Meng-Wei Wang; Ben-Yan Wu; Xin-Yan Yang; Wei-Hua Wang; Wei-Di You
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

8.  Phase II clinical trial of advanced and metastatic gastric cancer based on continuous infusion of 5-fluorouracil combined with epirubicin and oxaliplatin.

Authors:  Xiaodong Zhu; Jiin Leaw; Weilie Gu; Yiying Qian; Hongyu Du; Biyun Wang; Xiaonan Hong; Jiliang Yin
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-15       Impact factor: 4.553

Review 9.  Children's exposure to diagnostic medical radiation and cancer risk: epidemiologic and dosimetric considerations.

Authors:  Martha S Linet; Kwang Pyo Kim; Preetha Rajaraman
Journal:  Pediatr Radiol       Date:  2008-12-16

Review 10.  Epithelial-mesenchymal transition mediated tumourigenesis in the gastrointestinal tract.

Authors:  Ammar Natalwala; Robert Spychal; Chris Tselepis
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.